---
title: "Alphatec (NASDAQ:ATEC) Major Shareholder Squadron Capital Llc Sells 250,000 Shares"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/266090949.md"
description: "Squadron Capital LLC, a major shareholder of Alphatec Holdings, Inc. (NASDAQ:ATEC), sold 250,000 shares at $20.80 each, totaling $5.2 million. This sale reduced their ownership by 2.19%, leaving them with 11,145,045 shares. The transaction was disclosed to the SEC. Alphatec's stock traded at $19.74, with a market cap of $2.93 billion. Analysts have given the stock a positive outlook, with several raising their price targets."
datetime: "2025-11-16T23:28:57.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/266090949.md)
  - [en](https://longbridge.com/en/news/266090949.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/266090949.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/266090949.md) | [繁體中文](https://longbridge.com/zh-HK/news/266090949.md)


# Alphatec (NASDAQ:ATEC) Major Shareholder Squadron Capital Llc Sells 250,000 Shares

Alphatec Holdings, Inc. (NASDAQ:ATEC - Get Free Report) major shareholder Squadron Capital Llc sold 250,000 shares of the firm's stock in a transaction dated Wednesday, November 12th. The shares were sold at an average price of $20.80, for a total value of $5,200,000.00. Following the sale, the insider owned 11,145,045 shares in the company, valued at $231,816,936. This trade represents a 2.19% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Major shareholders that own 10% or more of a company's shares are required to disclose their sales and purchases with the SEC.

## Alphatec Price Performance

Shares of Alphatec stock traded down $0.46 during trading hours on Friday, reaching $19.74. 2,603,589 shares of the company's stock were exchanged, compared to its average volume of 2,130,456. Alphatec Holdings, Inc. has a 1 year low of $8.18 and a 1 year high of $21.16. The company has a market capitalization of $2.93 billion, a P/E ratio of -17.47 and a beta of 1.17. The business has a fifty day moving average of $15.99 and a two-hundred day moving average of $13.82. The company has a quick ratio of 1.77, a current ratio of 2.88 and a debt-to-equity ratio of 23.22.

Alphatec (NASDAQ:ATEC - Get Free Report) last issued its quarterly earnings results on Thursday, October 30th. The medical technology company reported $0.03 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.06) by $0.09. The business had revenue of $196.50 million for the quarter, compared to analysts' expectations of $182.78 million. The firm's revenue for the quarter was up 30.4% on a year-over-year basis. During the same quarter last year, the company earned ($0.28) earnings per share. Alphatec has set its FY 2025 guidance at EPS. As a group, research analysts predict that Alphatec Holdings, Inc. will post -1.08 earnings per share for the current fiscal year.

## Institutional Trading of Alphatec

A number of institutional investors and hedge funds have recently added to or reduced their stakes in ATEC. Teacher Retirement System of Texas acquired a new position in Alphatec during the first quarter worth $158,000. Envestnet Asset Management Inc. increased its position in shares of Alphatec by 1.2% during the 1st quarter. Envestnet Asset Management Inc. now owns 390,414 shares of the medical technology company's stock worth $3,959,000 after purchasing an additional 4,754 shares in the last quarter. New York State Common Retirement Fund lifted its holdings in Alphatec by 1.8% during the 1st quarter. New York State Common Retirement Fund now owns 1,224,005 shares of the medical technology company's stock valued at $12,411,000 after purchasing an additional 21,671 shares during the last quarter. CWM LLC boosted its position in Alphatec by 67.2% in the first quarter. CWM LLC now owns 31,336 shares of the medical technology company's stock valued at $318,000 after buying an additional 12,598 shares in the last quarter. Finally, Larson Financial Group LLC bought a new stake in Alphatec during the first quarter worth about $54,000. Institutional investors own 66.35% of the company's stock.

## Analyst Upgrades and Downgrades

Several equities research analysts have commented on ATEC shares. Wells Fargo & Company upped their price target on Alphatec from $14.00 to $16.00 and gave the stock an "overweight" rating in a research note on Thursday, October 16th. Morgan Stanley upped their price target on Alphatec from $16.00 to $21.00 and gave the company an "equal weight" rating in a report on Monday. Canaccord Genuity Group lifted their price objective on Alphatec from $20.00 to $25.00 and gave the company a "buy" rating in a research report on Friday, October 31st. Barclays raised their price objective on shares of Alphatec from $22.00 to $23.00 and gave the company an "overweight" rating in a research report on Monday, November 3rd. Finally, Lake Street Capital set a $25.00 target price on shares of Alphatec and gave the stock a "buy" rating in a research report on Friday, October 31st. Nine investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $22.00.

**Read Our Latest Report on Alphatec**

## Alphatec Company Profile

(Get Free Report)

Alphatec Holdings, Inc, a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. It manufactures and sells implants and instruments through third-party suppliers. The company offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application, which leverages EOS technology to more quickly quantify alignment parameters on a mobile device; SafeOp Neural InformatiX System that automates electromyographic and somatosensory evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems.

## See Also

-   Five stocks we like better than Alphatec
-   What Is WallStreetBets and What Stocks Are They Targeting?
-   If You Wait for the Dip, Micron Technology Could Leave You Behind
-   Why Invest in 5G? How to Invest in 5G Stocks
-   3 Stocks Quietly Powering the AI and Tech Revolution
-   Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
-   Jefferies Tells NVIDIA to Step Aside, Picks Broadcom as Top Semiconductor Stock

_This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com._

## Should You Invest $1,000 in Alphatec Right Now?

Before you consider Alphatec, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Alphatec wasn't on the list.

While Alphatec currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

### Related Stocks

- [Alphatec Holdings, Inc. (ATEC.US)](https://longbridge.com/en/quote/ATEC.US.md)

## Related News & Research

- [Top Alphatec Executive Makes Bold Multi-Million Dollar Stock Move](https://longbridge.com/en/news/279535541.md)
- [Morgan Stanley Increases Alphatec (NASDAQ:ATEC) Price Target to $21.00](https://longbridge.com/en/news/265386880.md)
- [Vitalist to Acquire Somatix, Pushing VitalOS Deeper Into Medical Wearables](https://longbridge.com/en/news/281221945.md)
- [New Survey Reveals About Cannabis-Related Health Risks](https://longbridge.com/en/news/281235535.md)
- [HYTN secures German cannabis market foothold with product release and reorder](https://longbridge.com/en/news/280854602.md)